Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.057 | 0.9 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |